Trailing-twelve-month (TTM) revenue is $79.67 Billion with a year-over-year growth of +49.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $17,600,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $19,292,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $19,799,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $22,974,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $79,665,800,000 |
Current P/S: $1,058,667,562,560 market capitalization ÷ $79,665,800,000 TTM revenue = 13.29x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T19:59:59.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $22.97B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Collaboration and Other Revenue | $1.8B | $2.4B | $3.1B | $5.3B | $4.3B | $4.2B |
| Product | $22.7B | $26.0B | $25.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $1.1B | $1.7B | $1.5B | $1.5B | $1.7B | $2.0B |
| Europe | $4.2B | $4.8B | $4.3B | $6.2B |
$79.67B
$79.67 Billion
+49.58%
vs. $53.26B a year ago (TTM)
+24.42%
5 Year compound annual growth rate
1 Year
+49.58%
3 Year
+39.22%
5 Year
+24.42%
10 Year
+14.48%
15 Year
+8.35%
20 Year
+8.69%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $65.18B | +$20.14B | +44.70% |
| 2024 | $45.04B | +$10.92B | +32.00% |
| 2023 | $34.12B | +$5.58B | +19.56% |
| 2022 | $28.54B | +$223.00M | +0.79% |
| 2021 | $28.32B | +$3.78B | +15.40% |
| 2020 |
TTM Growth
+49.58%
3-Year CAGR
+39.22%
5-Year CAGR
+24.42%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $40.7B |
| $61.0B |
| $11.6B |
| JAPAN | $2.6B | $2.4B | $1.7B | $1.7B | $1.8B | $2.1B |
|---|
| Non-US | N/A | $2.7B | $2.9B | $2.9B | $4.3B | $6.1B |
|---|
| Other Foreign Countries | $2.4B | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $14.2B | $16.8B | $18.2B | $21.8B | $30.4B | $43.5B |
|---|
| $24.54B |
| +$2.22B |
| +9.95% |
| 2019 | $22.32B | +$826.20M | +3.84% |
| 2018 | $21.49B | +$1.52B | +7.61% |
| 2017 | $19.97B | ($1.25B) | (5.88%) |
| 2016 | $21.22B | +$1.26B | +6.33% |
